January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

Stem cell therapy offers a minimally invasive alternative to joint replacement surgery, with recovery times of just one to two weeks compared to months for major surgery Clinical studies show varying ...

Autologous stem cell transplant for patients with diffuse systemic sclerosis (SSc), without selecting for a particular hematopoietic cell type, performed about as well in a new single-arm trial as was ...

Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye—called the ...

Dr. Christina Cho highlights the Adult Stem Cell Transplant and Cellular Therapy Program for its innovative research and compassionate, multidisciplinary team. Dr ...